Kalaris Therapeutics, Inc. (KLRS): 10-Q filed May 12, 2026

Form type

10-Q

Filing date

May 12, 2026

Accession number

0001193125-26-219328

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)